EMPLOYMENT AGREEMENTEmployment Agreement • February 27th, 2018 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • Massachusetts
This Employment Agreement (the "Agreement") is made and entered into effective as of this ____ day of ________, 20__ (the "Effective Date") by and between [Oxford lmmunotec, Inc., a Delaware corporation with a usual place of business at 700 Nickerson Road, Suite 200, Marlborough, MA 01752][Oxford Immunotec Limited, a private company limited by shares formed under the Laws of England and Wales, with a registered address of 94C Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ] (the "Company") and _________________ (the "Employee").
ContractPurchase Agreement • February 27th, 2018 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
Form of Officer STOCK OPTION AWARDOfficer Stock Option Award • February 27th, 2018 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
This agreement (this “Agreement”) evidences a stock option granted by Oxford Immunotec Global PLC (the “Company”) to the undersigned (the “Optionee”) pursuant to the Company’s 2013 Share Incentive Plan and Appendix D thereto (together, as amended from time to time, the “Plan”).
ContractDistributorship Agreement • February 27th, 2018 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
